American Heart Journal
Volume 156, Issue 1 , Pages 13-22 , July 2008

Body mass index and mortality in heart failure: A meta-analysis

  • Antigone Oreopoulos, MSc

      Affiliations

    • Department of Clinical Epidemiology, School of Public Health, University of Alberta, Edmonton, Alberta, Canada
    • ,
  • Raj Padwal, MD, MSc

      Affiliations

    • Division of General Internal Medicine, University of Alberta, Edmonton, Alberta, Canada
    • Corresponding Author InformationReprint requests: Raj Padwal, MD, MSc, Division of General Internal Medicine, University of Alberta, 2E3.22 Walter C. Mackenzie Health Sciences Center, 8440-112 Street, Edmonton, Alberta, Canada T6G 2B7.
    • ,
  • Kamyar Kalantar-Zadeh, MD, MPH, PhD

      Affiliations

    • Division of Nephrology and Hypertension, Harbor-UCLA Medical Center, Torrance, CA
    • ,
  • Gregg C. Fonarow, MD, FACC

      Affiliations

    • Division of Cardiology, UCLA David Geffen School of Medicine, Los Angeles, CA
    • ,
  • Colleen M. Norris, PhD

      Affiliations

    • Faculty of Nursing, University of Alberta, Edmonton, Alberta, Canada
    • ,
  • Finlay A. McAlister, MD, MSc

      Affiliations

    • Division of General Internal Medicine, University of Alberta, Edmonton, Alberta, Canada

Received 5 November 2007 ,Accepted 14 February 2008.

References 

  1. Kenchaiah S, Evans JC, Levy D, et al. Obesity and the risk of heart failure. N Eng J Med. 2002;347:305–313
  2. Kalantar-Zadeh K, Block G, Horwich T, et al. Reverse epidemiology of conventional cardiovascular risk factors in patients with chronic heart failure. J Am Coll Cardiol. 2004;43:1439–1444
  3. Anker S, Ponikowski P, Varney S, et al. Wasting as independent risk factor for mortality in chronic heart failure. Lancet. 1997;349:1050–1053
  4. Mariotti R, Castrogiovanni F, Becherini F, et al. Obesity, weight loss and heart failure. Eur Heart J. 2004;6(Suppl F):F87–F90
  5. Zuber M, Kaeslin T, Studer T, et al. Weight loss of 146 kg with diet and reversal of severe congestive heart failure in a morbidly obese patient. Am J Cardiol. 1999;84:955–956
  6. Malcom J, Arnold O, Howlett JG, et al. Canadian Cardiovascular Society Concensus Conference guidelines on heart failure—2008 updated: best practices for the transition of care of heart failure patients, and the recognition, investigation and treatment of cardiomyopathies. Can J Cardiol. 2008;24:21–40
  7. Physical status: the use and interpretation of anthropometry: report of a WHO Expert Committee. World Health Organization. 1995;854:1–452
  8. Pi-Sunyer FX, Becker DM, Bouchard C, et al. Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults. Bethesda (Md): National Institutes of Health in cooperation with the National Heart, Lung, and Blood Institute; 1998;[Publication NIH #98-4083]
  9. Wells G, Shea B, O'Connell D, et al. In: The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomized studies in meta-analysis. Ottawa Health Research Institute (OHRI); 2006;Available at: http://www.ohri.ca/programs/clinical_epidemiology/oxford.htmLast accessed May 22, 2008
  10. Hall J, French TK, Rasmusson KD, et al. The paradox of obesity in patients with heart failure. J Am Acad Nurse Prac. 2005;17:542–546
  11. Kristorp C, Faber J, Galatius S, et al. Plasma adiponectin, body mass index, and mortality in patients with chronic heart failure. Circulation. 2005;112:1756–1762
  12. Davos C, Dowhner W, Rauchhaus M, et al. Body mass and survival in patients with chronic heart failure without cachexia: the importance of obesity. J Cardiac Fail. 2003;9:29–35
  13. Kenchaiah S, Pocock S, Wang D, et al. Body mass index and prognosis in patients with chronic heart failure. Insights from the Candesartan in Heart failure. Circulation. 2007;116:627–636
  14. Higgins J, Thompson SG, Deeks JJ, et al. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557–560
  15. Bozkurt B, Deswal A. Obesity as a prognostic factor in chronic symptomatic heart failure. Am Heart J. 2005;150:1233–1239
  16. Gustafsson F, Kragelund CB, Torp-Pedersen C, et al. Effect of obesity and being overweight on long-term mortality in congestive heart failure: influence of left ventricular systolic function. Eur Heart J. 2005;26:58–64
  17. Cicoira M, Maggioni A, Latini R, et al. Body mass index, prognosis and mode of death in chronic heart failure: results from the Valsartan Heart Failure Trial. Eur J Heart Fail. 2007;9:397–402
  18. Butler J, Howser R, Portner PM, et al. Body mass index and outcomes after left ventricular assist device placement. Ann Thorac Surg. 2005;79:66–73
  19. Lavie C, Osman A, Milani R, et al. Body composition and prognosis in chronic systolic heart failure: the obesity paradox. Am J Cardiol. 2003;91:891–894
  20. Horwich T, Fonarow GC, Hamilton MA, et al. The relationship between obesity and mortality in patients with heart failure. J Am Coll Cardiol. 2001;38:789–795
  21. Pocock S, Wang D, Pfeffer MA, et al. Predictors of mortality and morbidity in patients with chronic heart failure. Eur Heart J. 2006;27:65–75
  22. Ho K, Keaven MA, Kannel WB, et al. Survival after the onset of congestive heart failure in Framingham Heart Study subjects. Circulation. 1993;88:107–115
  23. Mosterd A, Cost B, Hoes AW, et al. The prognosis of heart failure in the general population. Eur Heart J. 2001;22:1318–1327
  24. Lissin L, Gauri AJ, Froelicher VF, et al. The prognostic value of body mass index and standard exercise testing in male veterans with congestive heart failure. J Cardiac Fail. 2002;8:206–215
  25. Fonarow G, Srikanthan P, Costanzo MR, et al. An obesity paradox in acute heart failure: analysis of body mass index and inhospital mortality for 108927 patients in the Acute Decompensated Heart Failure National Registry. Am Heart J. 2007;153:74–81
  26. Kalantar-Zadeh K, Kilpatrick RD, Kuwae N, et al. Reverse epidemiology: a spurious hypothesis or a hardcore reality?. Blood Purification. 2005;23:57–63
  27. Ness A, Gunnell D, Hughes J, et al. Height, body mass index, and survival in men with coronary disease: follow up of the Diet and Reinfarction Trial (DART). J Epidemiol Community Health. 2002;218–219
  28. Oreopoulos A, Padwal R, Norris C, et al. Effect of obesity on short- and long-term mortality post coronary revascularization: a meta-analysis. Obesity. 2007;In Press
  29. Kalantar-Zadeh K, Kuwae N, Wu DY, et al. Associations of body fat and its changes over time with quality of life and prospective mortality in hemodialysis patients. Am J Clin Nutr. 2006;83:202–210
  30. Anker S, Rauchhaus M. Insights into the pathogenesis of chronic heart failure: immune activation and cachexia. Curr Opin Cardiol. 1999;14:211–216
  31. Grady K, Naftel D, Costanzo M, et al. Are preoperative obesity and cachexia risk factors for post heart transplant morbidity and mortality: a multi-institutional study of preoperative weight-height indices. J Heart Lung Transplant. 1999;18:750–763
  32. Berry C, Clark AL. Catabolism in chronic heart failure. Euro Heart J. 2000;21:521–532
  33. Anker S, Ponikowski PP, Clark AL, et al. Cytokines and neurohormones relating to body composition alterations in the wasting syndrome of chronic heart failure. Euro Heart J. 1999;20:683–693
  34. Anker S, Negassa A, Coats AJ, et al. Prognostic importance of weight loss in chronic heart failure and the effect of treatment with angiotensin-converting enzyme inhibitors: an observational study. Lancet. 2003;361:1077–1083
  35. Aquilani R, Opasich C, Verri M, et al. Is nutritional intake adequate in chronic heart failure patients?. J Am Coll Cardiol. 2003;42:1218–1223
  36. Freeman L, Roubenoff R. The nutrition implications of cardiac cachexia. Nutr Rev. 1994;52:340–347
  37. Imbearlt P, Tremblay A, Simoneau J, et al. Weight loss-induced rise in plasma pollutant is associated with reduced skeletal muscle oxidative capacity. Am J Physiol Endocrinol Metab. 2002;282:E574–E579
  38. Feldman A, Combes A, Wagner D, et al. The role of tumor necrosis factor in the pathophysiology of heart failure. J Am Coll Cardiol. 2000;35:537–544
  39. Mohamed-Ali V, Goodrick S, Bulmer K, et al. Production of soluble tumor necrosis factor receptors by human subcutaneous adipose tissue in vivo. Am J Physiol. 1999;277:E971–E975
  40. Koglin J, Pehlivanli S, Schwaiblmair M, et al. Role of brain natriuretic peptide in risk stratification of patients with congestive heart failure. J Am Coll Cardiol. 2001;38:1934–1941
  41. Horwich T, Hamilton MA, Fonarow GC. B-type natriuretic peptide levels in obese patients with advanced heart failure. J Am Coll Cardiol. 2006;47:85–90
  42. Schrier R, Abraham WT. Hormones and hemodynamics in heart failure. N Eng J Med. 1999;341:577–585
  43. Weber M, Neutel JM, Smith DHG. Contrasting clinical properties and exercise responses in obese and lean hypertensive patients. J Am Coll Cardiol. 2001;37:169–174
  44. Rauchhaus M, Coats AJS, Anker SD. The endotoxin–lipoprotein hypothesis. Lancet. 2000;356:930–933

 There was no project specific funding, but A.O. is supported by a CIHR Strategic Training Fellowship in Tomorrow's Research Cardiovascular Health Professionals; C.M.N. is supported by career salary awards from the Alberta Heritage Foundation for Medical Research; C.M.N. is also supported by New Investigator Awards from the Canadian Institutes of Health Research; G.C.F. is supported by a grant from the National Heart Lung and Blood Institute and the Eliot Corday Foundation; K.K. is supported by a grant from the National Institute of Diabetes, Digestive and Kidney Disease from the NIH and by a Grant-in-Aid from the American Heart Association; and F.A.M. is supported by career salary awards from AHFMR and CIHR as well as the Patient Health Management Chair at the University of Alberta.

PII: S0002-8703(08)00154-3

doi: 10.1016/j.ahj.2008.02.014

American Heart Journal
Volume 156, Issue 1 , Pages 13-22 , July 2008

Article Tools

* Image Usage & Resolution